Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RPL7L1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
NUP62 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HMGXB4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRM3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RWDD4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DUSP11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
METTL14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM120AOS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
TEFM - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RIT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SIK3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FRYL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBE2L3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NCBP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NBEAL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EDF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ELAC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPS21 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PWWP2B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on